Frontiers in Cardiovascular Medicine

Article	Citations
Long COVID 19 Syndrome: Is It Related to Microcirculation and Endothelial Dysfunction? Insights From TUN-EndCOV Study	127
Role of Lipid Accumulation and Inflammation in Atherosclerosis: Focus on Molecular and Cellular Mechanisms	114
Hydrophilic or Lipophilic Statins?	113
Vascular Tissue Engineering: Polymers and Methodologies for Small Caliber Vascular Grafts	108
Systemic immune-inflammation index as a potential biomarker of cardiovascular diseases: A systematic review and meta-analysis	93
The Role of the VEGF Family in Coronary Heart Disease	88
The Triglyceride-Glucose Index, an Insulin Resistance Marker, Was Non-linear Associated With All-Cause and Cardiovascular Mortality in the General Population	86
Foam Cells in Atherosclerosis: Novel Insights Into Its Origins, Consequences, and Molecular Mechanisms	85
COVID-19 in Relation to Hyperglycemia and Diabetes Mellitus	83
Targeting PAI-1 in Cardiovascular Disease: Structural Insights Into PAI-1 Functionality and Inhibition	83
Association Between Periodontal Disease and Atherosclerotic Cardiovascular Diseases: Revisited	82
Mechanisms of Oxidized LDL-Mediated Endothelial Dysfunction and Its Consequences for the Development of Atherosclerosis	82
COVID-19 and Heart Failure: From Epidemiology During the Pandemic to Myocardial Injury, Myocarditis, and Heart Failure Sequelae	81
Pivotal Role of TGF-β/Smad Signaling in Cardiac Fibrosis: Non-coding RNAs as Effectual Players	77
Association Between Triglyceride-Glucose Index and Hypertension: A Meta-Analysis	71
Application of Machine Learning in Diagnosis of COVID-19 Through X-Ray and CT Images: A Scoping Review	70
Relationship Between Sarcopenia and Cardiovascular Diseases in the Elderly: An Overview	68
Overview of Veno-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO) Support for the Management of Cardiogenic Shock	67
A Bibliometric Analysis of Exosomes in Cardiovascular Diseases From 2001 to 2021	64
Therapeutic Potential of Quercetin to Alleviate Endothelial Dysfunction in Age-Related Cardiovascular Diseases	64
First in-human quantitative plaque characterization with ultra-high resolution coronary photon-counting CT angiography	64
Myocarditis in SARS-CoV-2 infection vs. COVID-19 vaccination: A systematic review and meta-analysis	61
Early Detection of Checkpoint Inhibitor-Associated Myocarditis Using 68Ga-FAPI PET/CT	61
A Serpin With a Finger in Many PAIs: PAI-1's Central Function in Thromboinflammation and Cardiovascular Disease	60
SARS-CoV-2 Spike Protein Induces Degradation of Junctional Proteins That Maintain Endothelial Barrier Integrity	60

Endothelial Cells in Emerging Viral Infections	58
The Association of Plant-Based Diet With Cardiovascular Disease and Mortality: A Meta-Analysis and Systematic Review of Prospect Cohort Studies	58
Recent Development in Therapeutic Cardiac Patches	58
COVID-19 and the Heart: A Systematic Review of Cardiac Autopsies	57
The Link Between Ferroptosis and Cardiovascular Diseases: A Novel Target for Treatment	56
Long COVID-19 and Postural Orthostatic Tachycardia Syndrome- Is Dysautonomia to Be Blamed?	56
circSnx12 Is Involved in Ferroptosis During Heart Failure by Targeting miR-224-5p	55
Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms and Strategies for Cardioprotection	54
CD4+ T-lymphocytes exhibit biphasic kinetics post-myocardial infarction	53
Risk of Cardiovascular and Cerebrovascular Events in Polycystic Ovarian Syndrome Women: A Meta-Analysis of Cohort Studies	53
Regulation of PCSK9 Expression and Function: Mechanisms and Therapeutic Implications	53
Anti-inflammatory role of SGLT2 inhibitors as part of their anti-atherosclerotic activity: Data from basic science and clinical trials	53
Use of Multi-Modal Data and Machine Learning to Improve Cardiovascular Disease Care	53
Adipose Tissue Immunomodulation: A Novel Therapeutic Approach in Cardiovascular and Metabolic Diseases	53
miR-21 in Human Cardiomyopathies	53
Procedure-Related Complications of Left Bundle Branch Pacing: A Single-Center Experience	52
Inflammation in Metabolic Cardiomyopathy	52
Lipid Profile Features and Their Associations With Disease Severity and Mortality in Patients With COVID-19	51
Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors vs. Dipeptidyl Peptidase-4 (DPP4) Inhibitors for New-Onset Dementia: A Propensity Score-Matched Population-Based Study With Competing Risk Analysis	51
Sex and gender differences in myocarditis and dilated cardiomyopathy: An update	51
Sodium-Glucose Co-transporter-2 Inhibitor of Dapagliflozin Attenuates Myocardial Ischemia/Reperfusion Injury by Limiting NLRP3 Inflammasome Activation and Modulating Autophagy	51
Optimizing Outcomes in Cardiac Rehabilitation: The Importance of Exercise Intensity	50
Association of Systemic Immune-Inflammation Index With Short-Term Mortality of Congestive Heart Failure: A Retrospective Cohort Study	50
Wall shear stress and its role in atherosclerosis	49
Cardiac Fibrosis: Cellular Effectors, Molecular Pathways, and Exosomal Roles	49
Biomarkers for Heart Failure Prognosis: Proteins, Genetic Scores and Non-coding RNAs	49
The Predictive Value of Right Ventricular Longitudinal Strain in Pulmonary Hypertension, Heart Failure, and Valvular Diseases	49
Generation of SARS-CoV-2 Spike Pseudotyped Virus for Viral Entry and Neutralization Assays: A 1-Week Protocol	48
Hemodynamic Relevance of Anomalous Coronary Arteries Originating From the Opposite Sinus of Valsalva-In Search of the Evidence	48
Use of Direct Oral Anticoagulants in Patients With Antiphospholipid Syndrome: A Systematic Review and Comparison of the International Guidelines	48
The Role of Interleukin-6 Family Members in Cardiovascular Diseases	47
Hypertension as a risk factor for atherosclerosis: Cardiovascular risk assessment	47
Factor XI Inhibitors for Prevention and Treatment of Venous Thromboembolism: A Review on the Rationale and Update on Current Evidence	47
Protective Effects of Dexazoxane on Rat Ferroptosis in Doxorubicin-Induced Cardiomyopathy Through Regulating HMGB1	47
C-Reactive Protein Apheresis as Anti-inflammatory Therapy in Acute Myocardial Infarction: Results of the CAMI-1 Study	47
Microvascular Dysfunction in Patients With Type II Diabetes Mellitus: Invasive Assessment of Absolute Coronary Blood Flow and Microvascular Resistance Reserve	46
Gut Metabolite Trimethylamine-N-Oxide in Atherosclerosis: From Mechanism to Therapy	46
Diagnostic Accuracy of the HAS-BLED Bleeding Score in VKA- or DOAC-Treated Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis	46
Evidence for the Benefits of Melatonin in Cardiovascular Disease	45
Gestational Diabetes Mellitus and Preeclampsia: Correlation and Influencing Factors	45
Why Is COVID-19 More Severe in Patients With Diabetes? The Role of Angiotensin-Converting Enzyme 2, Endothelial Dysfunction and the Immunoinflammatory System	44
Prognostic Impact of Multiple Lymphocyte-Based Inflammatory Indices in Acute Coronary Syndrome Patients	44
Diagnostic and Prognostic Biomarkers for Myocardial Infarction	44
Impact of Metabolic Syndrome and It's Components on Prognosis in Patients With Cardiovascular Diseases: A Meta-Analysis	43
Telemedicine in Heart Failure During COVID-19: A Step Into the Future	43
Artificial intelligence in cardiology: Hope for the future and power for the present	43
Case report: Transplantation of human induced pluripotent stem cell-derived cardiomyocyte patches for ischemic cardiomyopathy	43
Evaluation of Endothelial Dysfunction and Inflammatory Vasculopathy After SARS-CoV-2 Infection—A Cross-Sectional Study	43
The Key Role of Uric Acid in Oxidative Stress, Inflammation, Fibrosis, Apoptosis, and Immunity in the Pathogenesis of Atrial Fibrillation	41
Endocan: A Key Player of Cardiovascular Disease	41

Atherogenic Index of Plasma and Coronary Artery Disease in the Adult Population: A Meta-Analysis	41
Sacubitril-Valsartan, Clinical Benefits and Related Mechanisms of Action in Heart Failure With Reduced Ejection Fraction. A Review	41
Antidepressant Drugs Effects on Blood Pressure	41
Radiomics Signatures of Cardiovascular Risk Factors in Cardiac MRI: Results From the UK Biobank	41
PCSK9 Functions in Atherosclerosis Are Not Limited to Plasmatic LDL-Cholesterol Regulation	40
Systemic Mesenchymal Stem Cell-Derived Exosomes Reduce Myocardial Infarct Size: Characterization With MRI in a Porcine Model	40
Gut Microbiota and Atherosclerosis—Focusing on the Plaque Stability	40
Machine Learning Approaches for Predicting Hypertension and Its Associated Factors Using Population-Level Data From Three South Asian Countries	40
Type 2 Diabetes and Myocardial Infarction: Recent Clinical Evidence and Perspective	40
Exosomes in Cardiovascular Diseases: Pathological Potential of Nano-Messenger	39
Cardiovascular diseases in Africa in the twenty-first century: Gaps and priorities going forward	39
Emerging Non-statin Treatment Options for Lowering Low-Density Lipoprotein Cholesterol	39
Promoting a Syndemic Approach for Cardiometabolic Disease Management During COVID-19: The CAPISCO International Expert Panel	39
Cardiomyocytes Cellular Phenotypes After Myocardial Infarction	39
Cardiac Fibrosis in the Pressure Overloaded Left and Right Ventricle as a Therapeutic Target	39
NLRP3 inflammasome: The rising star in cardiovascular diseases	39
Emerging Role of Adipocyte Dysfunction in Inducing Heart Failure Among Obese Patients With Prediabetes and Known Diabetes Mellitus	38
A Guide to Left Bundle Branch Area Pacing Using Stylet-Driven Pacing Leads	38
Microbiota-derived short-chain fatty acids: Implications for cardiovascular and metabolic disease	38
Acute Myocardial Infarction During the COVID-19 Pandemic: An Update on Clinical Characteristics and Outcomes	38
Post-ischemic Myocardial Inflammatory Response: A Complex and Dynamic Process Susceptible to Immunomodulatory Therapies	38
Robotic Cardiac Surgery in Europe: Status 2020	38
Metabolism and Chronic Inflammation: The Links Between Chronic Heart Failure and Comorbidities	38
Single Cell Transcriptomic Analysis Reveals Organ Specific Pericyte Markers and Identities	38
In-hospital arrhythmic burden reduction in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: Insights from the SGLT2-I AMI PROTECT study	37
Triglyceride Glucose Index Is Associated With Arterial Stiffness and 10-Year Cardiovascular Disease Risk in a Chinese Population	37
Prevalence of Atrial Fibrillation and Associated Mortality Among Hospitalized Patients With COVID-19: A Systematic Review and Meta-Analysis	37
Hypertension and COVID-19: Ongoing Controversies	37
Deep Learning for Detecting and Locating Myocardial Infarction by Electrocardiogram: A Literature Review	36
Gender-Related Differences in Heart Failure Biomarkers	36
Reduction of Cardiac Autonomic Modulation and Increased Sympathetic Activity by Heart Rate Variability in Patients With Long COVID	36
Aortic Stiffness: Epidemiology, Risk Factors, and Relevant Biomarkers	36
Alteration of m6A RNA Methylation in Heart Failure With Preserved Ejection Fraction	36
Targeting the microRNA-34a as a Novel Therapeutic Strategy for Cardiovascular Diseases	36
Senescence-Associated Secretory Phenotype as a Hinge Between Cardiovascular Diseases and Cancer	35
Fairness in Cardiac Magnetic Resonance Imaging: Assessing Sex and Racial Bias in Deep Learning-Based Segmentation	35
The Neutrophil-to-Lymphocyte Ratio Is an Important Indicator Predicting In-Hospital Death in AMI Patients	35
Statin Use in COVID-19 Hospitalized Patients and Outcomes: A Retrospective Study	35
COVID-19 vs. Classical Myocarditis Associated Myocardial Injury Evaluated by Cardiac Magnetic Resonance and Endomyocardial Biopsy	35
Telomere length and the risk of cardiovascular diseases: A Mendelian randomization study	35
Association of the Composite dietary antioxidant index with all-cause and cardiovascular mortality: A prospective cohort study	35
The Associations of Lipid Profiles With Cardiovascular Diseases and Death in a 10-Year Prospective Cohort Study	34
Epicardial Adipose Tissue and Cardiac Arrhythmias: Focus on Atrial Fibrillation	34
Serial EXTEM, FIBTEM, and tPA Rotational Thromboelastometry Observations in the Maastricht Intensive Care COVID Cohort—Persistence of Hypercoagulability and Hypofibrinolysis Despite Anticoagulation	34
Prevalence of Venous Thromboembolism in Critically Ill COVID-19 Patients: Systematic Review and Meta-Analysis	34
The atrial secondary tricuspid regurgitation is associated to more favorable outcome than the ventricular phenotype	34
Circulating Biomarkers for Cardiovascular Disease Risk Prediction in Patients With Cardiovascular Disease	34
The Link Between Sex Hormones and Susceptibility to Cardiac Arrhythmias: From Molecular Basis to Clinical Implications	34
Mechanisms of Atherosclerosis Induced by Postprandial Lipemia	34
A Novel Restorative Pulmonary Valve Conduit: Early Outcomes of Two Clinical Trials	34
The Interplay Between Adipose Tissue and Vasculature: Role of Oxidative Stress in Obesity	33
Carotid Intima-Media Thickness in Healthy Children and Adolescents: Normative Data and Systematic Literature Review	33
Association of the systemic immune-inflammation index with all-cause mortality in patients with arteriosclerotic cardiovascular disease	33
Left Ventricular Hypertrophy in Diabetic Cardiomyopathy: A Target for Intervention	33
Smoking and the Pathophysiology of Peripheral Artery Disease	33
Iron in Cardiovascular Disease: Challenges and Potentials	33
Diagnostic Value of sST2 in Cardiovascular Diseases: A Systematic Review and Meta-Analysis	33
Longevity Factor FOXO3: A Key Regulator in Aging-Related Vascular Diseases	33
The Effects of Fish Oil on Cardiovascular Diseases: Systematical Evaluation and Recent Advance	33
Gender Differences in Atherosclerotic Vascular Disease: From Lipids to Clinical Outcomes	33
Myofibroblast-Derived Exosome Induce Cardiac Endothelial Cell Dysfunction	33
Machine Learning for Clinical Decision-Making: Challenges and Opportunities in Cardiovascular Imaging	33
Electrocardiogram-Based Heart Age Estimation by a Deep Learning Model Provides More Information on the Incidence of Cardiovascular Disorders	33
Wnt Signaling in Vascular Calcification	33
Alpha2-Antiplasmin: The Devil You Don't Know in Cerebrovascular and Cardiovascular Disease	33
Role of MicroRNAs in the Pathogenesis of Coronary Artery Disease	32
Correlation Analysis of Hemoglobin-to-Red Blood Cell Distribution Width Ratio and Frailty in Elderly Patients With Coronary Heart Disease	32
Risk Factors for Anthracycline-Induced Cardiotoxicity	32
Incidence and Characterization of Concealed Cardiac Amyloidosis Among Unselected Elderly Patients Undergoing Post-mortem Examination	32
Identification of Potential Biomarkers and Immune Infiltration Characteristics in Idiopathic Pulmonary Arterial Hypertension Using Bioinformatics Analysis	32
Radiation-Induced Vascular Disease—A State-of-the-Art Review	32
Association Between Triglyceride Glucose Index and Risk of New-Onset Diabetes Among Chinese Adults: Findings From the China Health and Retirement Longitudinal Study	32
Cholesterol Efflux Capacity and Its Association With Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis	32
The Role of Artificial Intelligence in Cardiovascular Imaging: State of the Art Review	32
Myocardial Disease and Long-Distance Space Travel: Solving the Radiation Problem	32
Rheumatic Heart Valve Disease Pathophysiology and Underlying Mechanisms	32
Momordica. charantia-Derived Extracellular Vesicles-Like Nanovesicles Protect Cardiomyocytes Against Radiation Injury via Attenuating DNA Damage and Mitochondria Dysfunction	32
The Emerging Role of Neutrophil Extracellular Traps in Arterial, Venous and Cancer-Associated Thrombosis	31
Epicardial Fat Expansion in Diabetic and Obese Patients With Heart Failure and Preserved Ejection Fraction—A Specific HFpEF Phenotype	31
Burden of Peripheral Artery Disease and Its Attributable Risk Factors in 204 Countries and Territories From 1990 to 2019	31

Long-Term Clinical Outcomes in Patients With an Acute ST-Segment-Elevation Myocardial Infarction Stratified by Angiography-Derived Index of Microcirculatory Resistance	31
Ras Pathways on Prox1 and Lymphangiogenesis: Insights for Therapeutics	31
Shared Genetic Liability and Causal Associations Between Major Depressive Disorder and Cardiovascular Diseases	31
The Roles and Pharmacological Effects of FGF21 in Preventing Aging-Associated Metabolic Diseases	31
Safety profile of sodium glucose co-transporter 2 (SGLT2) inhibitors: A brief summary	31
Association Between Stress Hyperglycemia Ratio and In-hospital Outcomes in Elderly Patients With Acute Myocardial Infarction	31
Iron Deficiency: A New Target for Patients With Heart Failure	30
Recent Progress in in vitro Models for Atherosclerosis Studies	30
Chronic Obstructive Pulmonary Disease and the Cardiovascular System: Vascular Repair and Regeneration as a Therapeutic Target	30
Cinematic Rendering in Mixed-Reality Holograms: A New 3D Preoperative Planning Tool in Pediatric Heart Surgery	30
Endothelial to Mesenchymal Transition: An Insight in Atherosclerosis	30
Phenylacetylglutamine, a Novel Biomarker in Acute Ischemic Stroke	30
Gene Expression Profiling Reveals the Shared and Distinct Transcriptional Signatures in Human Lung Epithelial Cells Infected With SARS-CoV-2, MERS-CoV, or SARS-CoV: Potential Implications in Cardiovas	30
Causal Effect of the Triglyceride-Glucose Index and the Joint Exposure of Higher Glucose and Triglyceride With Extensive Cardio-Cerebrovascular Metabolic Outcomes in the UK Biobank: A Mendelian Random	30
Biventricular Longitudinal Strain Predict Mortality in COVID-19 Patients	30
Electronic Cigarette Use and the Risk of Cardiovascular Diseases	30
The Endothelial Glycocalyx: A Possible Therapeutic Target in Cardiovascular Disorders	30
Trends in Prevalence of Hypertension and Hypertension Phenotypes Among Chinese Children and Adolescents Over Two Decades (1991–2015)	30
Update on Transcatheter Tricuspid Valve Replacement Therapies	30
Mechanism of action and therapeutic use of bempedoic acid in atherosclerosis and metabolic syndrome	30
Cardiac Rehabilitation: A Bibliometric Review From 2001 to 2020	30
Cardiovascular effects of immunosuppression agents	29
Effects of High-Intensity Interval vs. Moderate-Intensity Continuous Training on Cardiac Rehabilitation in Patients With Cardiovascular Disease: A Systematic Review and Meta-Analysis	29
Cost-Effectiveness Evaluation of Add-on Empagliflozin in Patients With Heart Failure and a Reduced Ejection Fraction From the Healthcare System's Perspective in the Asia-Pacific Region	29
Improving Diuretic Response in Heart Failure by Implementing a Patient-Tailored Variability and Chronotherapy-Guided Algorithm	29
miR-135b-3p Promotes Cardiomyocyte Ferroptosis by Targeting GPX4 and Aggravates Myocardial Ischemia/Reperfusion Injury	29
Studying the Endothelial Glycocalyx in vitro: What Is Missing?	29
COVID-19 and Acute Coronary Syndromes: Current Data and Future Implications	29
Obesity and Cardiovascular Disease: The Emerging Role of Inflammation	29
The Notch Pathway: A Link Between COVID-19 Pathophysiology and Its Cardiovascular Complications	29
Electrocardiogram classification using TSST-based spectrogram and ConViT	29
Prognostic Outcomes in Acute Myocardial Infarction Patients Without Standard Modifiable Risk Factors: A Multiethnic Study of 8,680 Asian Patients	29
A 20-year journey in transcatheter aortic valve implantation: Evolution to current eminence	29
Causal associations between gut microbiome and cardiovascular disease: A Mendelian randomization study	29
Territory-Wide Chinese Cohort of Long QT Syndrome: Random Survival Forest and Cox Analyses	29
The Role of MSC Therapy in Attenuating the Damaging Effects of the Cytokine Storm Induced by COVID-19 on the Heart and Cardiovascular System	28
Lipid-Laden Macrophages and Inflammation in Atherosclerosis and Cancer: An Integrative View	28
Partitioning the Right Ventricle Into 15 Segments and Decomposing Its Motion Using 3D Echocardiography-Based Models: The Updated ReVISION Method	28
Association between the weight-adjusted-waist index and abdominal aortic calcification in United States adults: Results from the national health and nutrition examination survey 2013–2014	28
Predictive Value of Gensini Score in the Long-Term Outcomes of Patients With Coronary Artery Disease Who Underwent PCI	28
Mitochondria in Pathological Cardiac Hypertrophy Research and Therapy	28
Role of Exosomal miRNAs in Heart Failure	28
Historical Context of Cardiac Rehabilitation: Learning From the Past to Move to the Future	28
New Developments in Exosomal lncRNAs in Cardiovascular Diseases	28
Where the Action Is—Leukocyte Recruitment in Atherosclerosis	28
Mitochondrial Metabolism in Myocardial Remodeling and Mechanical Unloading: Implications for Ischemic Heart Disease	28
Cardiovascular Outcome in Patients Treated With SGLT2 Inhibitors for Heart Failure: A Meta-Analysis	28
Sulodexide Significantly Improves Endothelial Dysfunction and Alleviates Chest Pain and Palpitations in Patients With Long-COVID-19: Insights From TUN-EndCOV Study	28
The intersection of obesity and (long) COVID-19: Hypoxia, thrombotic inflammation, and vascular endothelial injury	28
Viral Myocarditis: Classification, Diagnosis, and Clinical Implications	28
Comparison of three non-insulin-based insulin resistance indexes in predicting the presence and severity of coronary artery disease	28
Left Bundle Branch Pacing: Current Knowledge and Future Prospects	28
Myocardial Work Efficiency, A Novel Measure of Myocardial Dysfunction, Is Reduced in COVID-19 Patients and Associated With In-Hospital Mortality	28
Cardiac Remodeling After Myocardial Infarction: Functional Contribution of microRNAs to Inflammation and Fibrosis	27
The Pathogenic Role of Long Non-coding RNA H19 in Atherosclerosis via the miR-146a-5p/ANGPTL4 Pathway	27
Glycolysis Inhibition Alleviates Cardiac Fibrosis After Myocardial Infarction by Suppressing Cardiac Fibroblast Activation	27
Prevalence and Prognosis of HFimpEF Developed From Patients With Heart Failure With Reduced Ejection Fraction: Systematic Review and Meta-Analysis	27
Anticoagulant SERPINs: Endogenous Regulators of Hemostasis and Thrombosis	27
Roles of Ferroptosis in Cardiovascular Diseases	27
Cardiac Involvement in Recovered Patients From COVID-19: A Preliminary 6-Month Follow-Up Study	27
Atrial Fibrillation and Depression: A Bibliometric Analysis From 2001 to 2021	27
Neutrophil-Platelet Interactions as Novel Treatment Targets in Cardiovascular Disease	27
MiR-223-3p in Cardiovascular Diseases: A Biomarker and Potential Therapeutic Target	27
Intravascular Ultrasound in the Endovascular Treatment of Patients With Peripheral Arterial Disease: Current Role and Future Perspectives	27
Environmental Risk Factors and Congenital Heart Disease: An Umbrella Review of 165 Systematic Reviews and Meta-Analyses With More Than 120 Million Participants	27
The Research Progress of Trastuzumab-Induced Cardiotoxicity in HER-2-Positive Breast Cancer Treatment	27
Proprotein Convertase Subtilisin/Kexin Type 9 and Inflammation: An Updated Review	27
Association Between Dietary Inflammatory Index and Heart Failure: Results From NHANES (1999–2018)	27
Polymeric prosthetic heart valves: A review of current technologies and future directions	27
Cognitive Impairment in Heart Failure: Landscape, Challenges, and Future Directions	27
Right Ventricular Damage in COVID-19: Association Between Myocardial Injury and COVID-19	27
Prognostic Significance of Triglyceride-Glucose Index for Adverse Cardiovascular Events in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis	27
Novel Approaches in Cardiac Imaging for Non-invasive Assessment of Left Heart Myocardial Fibrosis	27
Regulation of Endothelial and Vascular Functions by Carbon Monoxide via Crosstalk With Nitric Oxide	27
Oral, Tongue-Coating Microbiota, and Metabolic Disorders: A Novel Area of Interactive Research	26
Immune checkpoint inhibitor therapy increases systemic SDF-1, cardiac DAMPs Fibronectin-EDA, S100/Calgranulin, galectine-3, and NLRP3-MyD88-chemokine pathways	26
Sex–Gender Disparities in Cardiovascular Diseases: The Effects of Estrogen on eNOS, Lipid Profile, and NFATs During Catecholamine Stress	26
Case Report: Hyperbilirubinemia in Gilbert Syndrome Attenuates Covid-19-Induced Metabolic Disturbances	26
Left Ventricular Myocardial Septal Pacing in Close Proximity to LBB Does Not Prolong the Duration of the Left Ventricular Lateral Wall Depolarization Compared to LBB Pacing	26
Smartwatch Electrocardiograms for Automated and Manual Diagnosis of Atrial Fibrillation: A Comparative Analysis of Three Models	26
Interpretable machine learning for 28-day all-cause in-hospital mortality prediction in critically ill patients with heart failure combined with hypertension: A retrospective cohort study based on med	26
Fibrinolytic Serine Proteases, Therapeutic Serpins and Inflammation: Fire Dancers and Firestorms	26
Gut Microbiota Dysbiosis in Human Hypertension: A Systematic Review of Observational Studies	26
Post-operative Right Ventricular Failure After Cardiac Surgery: A Cohort Study	26
Hypertension is prevalent in non-alcoholic fatty liver disease and increases all-cause and cardiovascular mortality	26
Dysbiosis of Gut Microbiota and Metabolite Phenylacetylglutamine in Coronary Artery Disease Patients With Stent Stenosis	26
Feasibility and Outcomes of Upgrading to Left Bundle Branch Pacing in Patients With Pacing-Induced Cardiomyopathy and Infranodal Atrioventricular Block	26
Soluble Platelet Release Factors as Biomarkers for Cardiovascular Disease	26
Uncoupling the Vicious Cycle of Mechanical Stress and Inflammation in Calcific Aortic Valve Disease	26
Diagnostic Value of Angiography-Derived IMR for Coronary Microcirculation and Its Prognostic Implication After PCI	26
The Role of Ferroptosis in Cardiovascular Disease and Its Therapeutic Significance	25
Microvascular Angiopathic Consequences of COVID-19	25
Luteolin Prevents Cardiac Dysfunction and Improves the Chemotherapeutic Efficacy of Doxorubicin in Breast Cancer	25
COVID-19 and Cardiomyopathy: A Systematic Review	25
Association of Lipid Levels With COVID-19 Infection, Disease Severity and Mortality: A Systematic Review and Meta-Analysis	25